We are
the universal choice
in cranial products
About Us
EncephalX is committed to redefining the standard of care for patients with traumatic brain injuries or strokes. Conventionally treated in two surgeries, our Dynamic Cranioplasty System (DCPS) offers a safer, more efficient solution that enhances patient outcomes and reduces recovery time with a streamlined, single-procedure approach.
With a diverse team of professionals specializing in engineering, neurosurgery, clinical research and regulatory affairs, we focus on providing tangible, real-world solutions to complex challenges in the operating room, ultimately improving the quality of life for patients.
Our mission
To improve the quality of life of patients treated through neurosurgery with adapted products that promote a rapid and uncomplicated recovery.
We aspire to become a world leader in the development, certification and commercialization of dynamic implants.
Towards the summit of medical devices
We aspire to become a world leader in the development, certification and commercialization of dynamic implants.
Universal device,
a peace of mind
The DCPS's simplicity, will ensure trouble-free surgeries, keeping patients and health care professionals' heads at peace.
Benefits
for both parties.
2nd surgery
avoided
By eliminating the need for a second surgery, the risks associated with the treatment will be considerably reduced.
Safe
Surgery
Our device provides a cerebral protection that limits the possibility of injuries caused by impacts and removes the risk of skin collapse, better known as "sinking flap syndrome".
Improved
Aesthetic
As one of the thinnest plates available on the market, it will promote rapid healing to improve the appearance of scars.
Reduced
time
The rehabilitation period for the surgical treatment of an increased intracranial pressure will now be reduced by several weeks due to the combined procedure.
Need more information ?
Do not hesitate to contact us for more information. It will be our pleasure to answer you and to better inform you on the company, the projects and the next steps for EncephalX.
Solutions
to everyday problems
Head injuries are the leading cause of death for young adults in North America. However, the care provided is associated to a lot of complications and is very costly for the health care system. The treatment involves the removal of a large part of the skull for a period of two months. After this initial procedure, these patients' brains are left extremely vulnerable until their bone flap is reinstalled during the second surgery.
Our team
Simon Lapointe
CEO & Founder
Marie-Christine Lambert
Certification Manager
Dr Christian Iorio-Morin
CMO & Neurosurgeon
Elizabeth Rivard
R&D
Louis-Philippe Riel
CTO
Business Advisors
Jean-François Côté
Fractional CFO
Stéphane Gagné
Serial entrepreneur
& funding strategist
Danièle Grondines
Regulatory strategy
Claude Lapointe
Business management
expertise
News
Funding
EncephalX is currently raising its Pre-Seed #2. By exceeding expectations in our latest cadaveric trials, we are now looking to complete the final regulatory requirements to launch our clinical trials by the end of 2025.
EncephalX is seeking to close a $1.5M round by June 2025 with partners who are eager to invest in a high-potential project while having a positive impact on the community. Please contact us for more information.
Scientific Committee
Dr Louis Crevier
Neurosurgeon
Dr Pierre Duval
Orthopedic Surgeon
Joannie Gravel
Surgical Nurse Specialist
Dr David Mathieu
Neurosurgeon
